🚀 Exciting times ahead! Myllia Biotechnology is headed to #BIO2024 in San Diego! Looking forward to connecting with top #biotech and #pharma companies to drive innovation in target discovery. #crispr #research

Recently, Myllia Biotechnology gathered next to the Vienna BioCenter for a new 2024 group picture - it's great to have you all on board to tackle exciting #CRISPR #screening projects with biotech and pharma clients across the globe! 🚀#TeamMyllia #Vienna ➡️myllia.com

🔊 Job alert! - We are #hiring a Lab Associate/Lab Scientist at Myllia Biotechnology in Vienna, Austria! If you are fascinated about functional genomics and primary immune cell biology, please send us your application via [email protected] - myllia.com/careers/ #TeamMyllia #CRISPR

Join us at #BIOEurope 2024 in Stockholm! We look forward to discussing new CRISPR screening #partnerships for target ID/validation and drug discovery. myllia.com #TeamMyllia #CRISPR #Screening #FGX

We're #hiring a Lab Associate/Lab Scientist at Myllia Biotechnology in Vienna, Austria! Check out the job description online, if you're fascinated by CRISPR, functional genomics and cell biology: myllia.com/careers/ #TeamMyllia #job

I am representing Myllia Biotechnology at Single-Cell Genomics 2024 in Paris, France - thanks to Institut Imagine for hosting the event! Reach out to discuss your next #CRISPR #screening and #functional #genomics projects for drug target discovery in single cells! myllia.com

At Myllia Biotechnology, we use single-cell #CRISPR screens for target discovery in challenging cell models, e.g., primary T cells. Watch the latest #interview with Tilmann Bürckstümmer at @ELRIG_UK Drug Discovery 2024 and reach out to discuss your next CRISPR project! youtu.be/9Po9Tlvrrgk?si…

Did you know Myllia Biotechnology has a #YouTube channel? If you like, check out some of the edutainment videos we've created to showcase our single-cell #CRISPR #screening platform! Become "famyllia" with CROP-Seq (Perturb-Seq): youtu.be/8TS794MDHwg?si…

🔬 At Myllia Biotechnology, we're revolutionizing target discovery with CROP-Seq in primary human T cells: - Custom assay development - SLICE protocol for functional screening - Integration of CITE-Seq & scRNA-Seq Ready to elevate your research? Contact us via: myllia.com

Can #AI predict #CRISPR perturbation outcomes? Myllia Biotechnology's CROP-Seq dataset provides a critical resource for AI-driven #Foundation #Models of the Human Cell: CROP-Seq training datasets for AI-based foundation models of human cell biology — Myllia

📢 One month to go! Myllia Biotechnology will be at #BIOEuropeSpring 2025 in Milan, Italy! Would you like to get in touch? Meet our BD Manager Henrik Schmidt on site to explore #CRISPR-based #functional #genomics screens in primary human cells! Learn more here: myllia.com

🧬 At Myllia Biotechnology, we're pushing the boundaries of scCRISPR screens in primary human T cells. For example, we focus on scalable CROP-Seq screens to uncover key mediators of T helper cell differentiation, particularly Th2 cells! myllia.com #CRISPR #scRNASeq #TCells

A team at Myllia Biotechnology contributed one of the largest single-cell CRISPR perturbation screens published today: nature.com/articles/s4155… The lab of Wei Li developed the perturbation-response score (PS) allowing the quantification of diverse perturbation responses in single cells!

🚀 At Myllia Biotechnology, we're advancing scRNA-Seq in primary human cells with our targeted sequencing (TA-Seq) platform! Key insights: • TA-Seq uses 10K reads/cell vs. 50K reads/cell for WTA • Low-abundance mRNAs are detected more effectively with TA-Seq myllia.com

We will be at #AACR25 in Chicago, USA Poster presentation: "A compressed genome-wide CROP-Seq screen to dissect the polarization of THP-1-derived macrophages" 🎯 When: Sunday, April 27 from 2.00 - 5.00 PM EST 🎯 Poster: LB043, Section 52 myllia.com #CRISPR

Looking forward to representing Myllia Biotechnology at the #SwissBiotechDay 2025 in Basel and discussing drug target ID/validation powered by single-cell CRISPR screens in primary human cells! 🎯 Explore Myllia's platform: myllia.com 📩 Contact: [email protected]

It's about one month to go until BIO US 2025 in Boston! Are you attending as well? If so, please reach out to our CSO Tilmann Bürckstümmer and our BD Manager Henrik Schmidt who will be attending #BIO2025 from June 16-19, 2025. Contact us via: 📩 [email protected] 📰 myllia.com

🧬 Unlocking target discovery in primary human dendritic cells with VISTA™ At Myllia Biotechnology, we’re enabling high-throughput functional genomics in primary immune cells. Our VISTA™ platform combines pooled CRISPRi with scRNA-Seq to map gene function at scale! E: [email protected]

🗓️ Myllia Biotechnology sponsors the first conference on "High-Content CRISPR Screening" from March 18-19, 2026 in Vienna: perturb2026.bio 🔬 CRISPR-based screening strategies 🧬 Perturb-Seq & CROP-Seq 💻 Computational analyses 💻 AI models of human cells 📸 Image-based screens

📢 Myllia Biotechnology is heading to #IUIS2025 - we’re excited to share that Anke Loregger, Myllia’s Director of R&D, will be attending the International Congress of Immunology (IUIS) 2025 in Vienna! Poster: II.265 on Wednesday, August 20 at 12.15 PM